CC
Chemours Co
14.50$
+1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.0% | -3.5% | +14.1% | -3.4% | -7.1% | -1.9% | +18.1% | -7.4% | -11.0% | +3.8% | +15.2% | – | |
| – | -4.7% | -6.8% | +15.6% | -2.5% | -7.7% | +1.0% | +18.1% | -5.8% | -6.6% | -0.9% | +11.9% | – | |
| – | -6.6% | +11.4% | +8.5% | -7.1% | -4.5% | -13.6% | +17.8% | -15.5% | -34.9% | +40.5% | +33.0% | – | |
| – | -46.4% | +86.7% | -7.1% | +11.5% | -10.3% | +3.8% | +3.7% | -7.1% | +3.8% | -3.7% | +3.8% | – | |
| – | +35.2% | -37.7% | +0.0% | -2.9% | +6.7% | -14.6% | +255.3% | -75.1% | +19.3% | +13.1% | +219.0% | – | |
| – | -9.2% | +15.5% | +4.1% | -7.9% | +20.7% | -20.2% | +30.4% | -36.4% | +214.5% | -63.3% | +230.5% | – | |
| – | -2.7% | +5.6% | +15.0% | -6.2% | -38.5% | +4.0% | -7.7% | +44.4% | -349.0% | – | -432.8% | – | |
| – | +14.5% | +0.0% | +4.8% | +4.5% | -2.9% | -1.5% | +0.0% | +3.0% | +1.5% | -1.4% | +0.0% | – | |
| – | -630.8% | – | -1.4% | -143.5% | – | +766.7% | -434.6% | – | -384.3% | – | – | – | |
| – | -5,400.0% | – | -43.8% | -133.3% | – | +382.4% | +45.1% | -107.6% | – | – | +3,800.0% | – | |
| – | -250.0% | – | +11.1% | -145.0% | – | – | – | – | -201.7% | – | – | – | |
| – | +18.1% | +20.0% | +2.5% | -44.0% | +31.6% | +0.0% | -174.7% | – | -138.4% | – | -430.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.